| Name | Title | Contact Details |
|---|
MISSION is the first and only line of athlete-engineered products designed to enhance performance in training and competition. Co-founded in 2009 by a premier group of world-class athletes including Serena Williams, Dwyane Wade, Sergio Garcia, David Wright, Reggie Bush and Mia Hamm, MISSION boasts more than 25 high-performance product innovations and is sold in nearly 20,000 stores across the U.S. MISSION works with its world-renowned athletes, doctors and scientists to engineer products that help athletes prepare, perform and rehab from training or competition.
LiteCure is a Newark, DE-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Signify Health exists to drive more healthy, happy days at home. That`s why we`re committed to accelerating the movement to value-based care, transforming how care is paid for and delivered, and sharing accountability for driving better outcomes for the individuals and families we all serve. Today, Signify Health is privileged to impact the lives of millions of people every year. Our high-performance provider and community networks—which includes the nation`s largest field-based network of doctors and nurse practitioners—reaches and engages people anywhere in the U.S. With powerful analytics and clinical expertise, we support individuals` health journeys from the acute care facility to the ideal next site of care and all the way to a place of residence, helping them get home sooner and stay there longer. This is how we`re transforming a fragmented healthcare system into one that`s value-based, human-centered, and drives more healthy and happy days at home.
American Society of Plastic Surgeons is a Arlington Heights, IL-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
Volition is a multi-national epigenetics company that applies its Nucleosomics™ platform through its subsidiaries to develop simple, easy to use, cost effective blood tests to help diagnose and monitor a range of life-altering diseases including some cancers and diseases associated with NETosis such as sepsis and COVID-19. Early diagnosis and monitoring have the potential to not only prolong the life of patients but also improve their quality of life. The tests are based on the science of Nucleosomics™, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. Volition is primarily focused on human diagnostics and monitoring but also has a subsidiary focused on animal diagnostics and monitoring. Volition`s research and development activities are centered in Belgium, with an innovation laboratory in California and additional offices in Texas, London, and Singapore, as the company focuses on bringing its diagnostic and disease monitoring products to market.